(PDF) MA19.09 Concurrent Mutations in STK11 and KEAP1 Is

MA19.09 Concurrent Mutations in STK11 and KEAP1 Is Associated With Resistance to PD-(L)1 Blockade in Patients With NSCLC Despite High TMB

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.480

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients

Journal of Cancer

Oncology

2019

English

P2.01-21 Antigen Cascade Triggering Correlates With Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade With Nivolumab.

Journal of Thoracic Oncology

English

High TMB Predicts Immunotherapy Benefit in NSCLC

Cancer Discovery

Oncology

2018

English

Radiotherapy May Sensitize to CTLA4 Blockade in Patients With NSCLC

Cancer Discovery

Oncology

2018

English

Local and Abscopal Responses in Advanced Intrahepatic Cholangiocarcinoma With Low TMB, MSS, pMMR and Negative PD-L1 Expression Following Combined Therapy of SBRT With PD-1 Blockade

Journal for ImmunoTherapy of Cancer

English

TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma

Nature Communications

English

Efficacy of PD-1 Blockade in Cervical Cancer Is Related to a CD8+FoxP3+CD25+ T-Cell Subset With Operational Effector Functions Despite High Immune Checkpoint Levels

Journal for ImmunoTherapy of Cancer

English

Rilpivirine Resistance-Associated Mutations Among Antiretroviral-Naive Patients Infected With HIV-1 in Asia

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2013

English

Pmd74 - High Resolution Melting for the Screening of Resistance-Associated Mutations in Mycobacterium Leprae in Leprosy Patients With Suspected Relapse Associated With Resistance.

English

Amanote Research

MA19.09 Concurrent Mutations in STK11 and KEAP1 Is Associated With Resistance to PD-(L)1 Blockade in Patients With NSCLC Despite High TMB

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.480

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients

P2.01-21 Antigen Cascade Triggering Correlates With Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade With Nivolumab.

High TMB Predicts Immunotherapy Benefit in NSCLC

Radiotherapy May Sensitize to CTLA4 Blockade in Patients With NSCLC

Local and Abscopal Responses in Advanced Intrahepatic Cholangiocarcinoma With Low TMB, MSS, pMMR and Negative PD-L1 Expression Following Combined Therapy of SBRT With PD-1 Blockade

TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma

Efficacy of PD-1 Blockade in Cervical Cancer Is Related to a CD8+FoxP3+CD25+ T-Cell Subset With Operational Effector Functions Despite High Immune Checkpoint Levels

Rilpivirine Resistance-Associated Mutations Among Antiretroviral-Naive Patients Infected With HIV-1 in Asia

Pmd74 - High Resolution Melting for the Screening of Resistance-Associated Mutations in Mycobacterium Leprae in Leprosy Patients With Suspected Relapse Associated With Resistance.